Anzeige
Mehr »
Montag, 06.07.2026 - Börsentäglich über 12.000 News
8,8-Mio.-Nanocap direkt neben Europas Lithium-Giganten - jetzt steigt die Spannung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
287 Leser
Artikel bewerten:
(0)

Phoenix Rising Companies Announces Definitive MOU To Acquire High Tech Medical Products Distribution Company

PARK CITY, UT / ACCESSWIRE / February 28, 2022 / Phoenix Rising Companies (OTCQB:PRCX):

DS Chang, CEO and Chairman of the company is pleased to announce the completion of a definitive MOU to acquire 100% ownership of Emvera Technologies, LLC, based in the greater Atlanta area.

Founded in 2012, Emvera is focused on distributing various lines of aesthetic medical devices, including state-of- the-art lasers and energy-based systems.

The market for aesthetic or "vanity" treatments is growing steadily year over year. According to Grandview Research, the US market size in 2021 was $53.8 Billion USD, with a predicted compound annual growth rate of 15.2% annually through at least 2030.

Emvera's customers include doctors, medical professionals and aesthetic practitioners who

acquire the devices for use in a variety of treatments such as skin resurfacing, skin renewal and hair removal.

Emvera offers attractive financing options for their customers, with industry-leading transferable warranties, trade-in programs and reasonably priced consumables.

Following years of profitable operations, the worldwide pandemic had a negative impact on Emvera's business for the prior two years. However, this has also created opportunities for Emvera, including pending strategic alliances which it has been pursing during the last six months. In addition, sales and activity in the industry are starting to return to pre-pandemic levels.

Emvera's CEO is Eric Fuller, a long-time advisor to Phoenix and its Vice President of U.S. sales, with over 20 years of experience, and well known for his integrity and expertise.

The MOU calls for a host of additional steps, including the issuance of about 46 million common restricted shares of Phoenix and creation of financing for Emvera operations

pursuant to a formal acquisition agreement in the next 90 days.

In addition to this MOU, Phoenix continues to press forward with R&D projects and additional acquisitions, with an eye towards developing Western hemisphere subsidiaries and divisions which hold the promise growth, sustainability and profitability.

Interested parties can learn more about Emvera by visiting www.emvera.com

Additional information will be announced as it becomes available.

For information on Phoenix Rising Companies visit www.phoenix-cos.com

contact ir@phoenix-cos.com

CAUTIONARY STATEMENT

This press release contains forward-looking statements. Known and unknown risks may cause actual future results to vary widely. The statements are based upon Management's and Advisor's current expectations, estimates and projections; are not guarantees of future performance and are subject to certain risks and uncertainties and other factors, some of which are beyond Management's control and are difficult to predict. A reader of this press release should not place undue reliance on forward-looking statements. Investors should understand investing in shares of RSSV involves a high degree of risk and should seek competent investment advice prior to purchasing shares.

SOURCE: Phoenix Rising Companies



View source version on accesswire.com:
https://www.accesswire.com/690597/Phoenix-Rising-Companies-Announces-Definitive-MOU-To-Acquire-High-Tech-Medical-Products-Distribution-Company

© 2022 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.